IIHL to Raise Rs 3,000 Crore via NCDs for Reliance Capital Acquisition
By Rediff Money Desk, New Delhi Sep 09, 2024 20:49
IIHL, the successful bidder for Reliance Capital, plans to raise Rs 3,000 crore through NCDs to fund the acquisition. The move follows NCLT's approval of IIHL's resolution plan for the debt-ridden firm.
New Delhi, Sep 9 (PTI) Hinduja Group firm IIHL, the successful resolution applicant for takeover of debt-ridden Reliance Capital (RCAP), on Monday filed offer documents to raise Rs 3,000 crore through non-convertible debentures (NCDs), according to sources.
The proceeds will be used to part fund the acquisition of RCAP, while the other leg of the transaction to complete the process for Rs 4,300 crore is parallelly underway which will be subject to receipt of regulatory approvals and completion of formalities by the administrator, sources said.
IndusInd International Holdings Ltd (IIHL) has filed the NCD offer document with the BSE.
The NCD -- with a duration of 3.5 years -- is expected to open for subscription early next week, sources said.
IIHL has already brought its equity component of Rs 2,750 crore for the transaction, which has been deposited in a designated account of the Committee of Creditors, under the supervision of NCLT.
The NCLT Mumbai on February 27, 2024, approved IIHL's Rs 9,650-crore resolution plan for the debt-ridden financial firm.
In November 2021, the Reserve Bank of India superseded the board of Reliance Capital on governance issues and payment defaults by the Anil Dhirubhai Ambani Group company.
The central bank had appointed Nageswara Rao Y as the administrator, who invited bids in February 2022 to take over the company.
Reliance Capital had a debt of over Rs 40,000 crore, and four applicants had initially bid with resolution plans. However, the committee of creditors rejected all four plans for lower bid values and a challenge mechanism was initiated in which IIHL and Torrent Investments participated.
The proceeds will be used to part fund the acquisition of RCAP, while the other leg of the transaction to complete the process for Rs 4,300 crore is parallelly underway which will be subject to receipt of regulatory approvals and completion of formalities by the administrator, sources said.
IndusInd International Holdings Ltd (IIHL) has filed the NCD offer document with the BSE.
The NCD -- with a duration of 3.5 years -- is expected to open for subscription early next week, sources said.
IIHL has already brought its equity component of Rs 2,750 crore for the transaction, which has been deposited in a designated account of the Committee of Creditors, under the supervision of NCLT.
The NCLT Mumbai on February 27, 2024, approved IIHL's Rs 9,650-crore resolution plan for the debt-ridden financial firm.
In November 2021, the Reserve Bank of India superseded the board of Reliance Capital on governance issues and payment defaults by the Anil Dhirubhai Ambani Group company.
The central bank had appointed Nageswara Rao Y as the administrator, who invited bids in February 2022 to take over the company.
Reliance Capital had a debt of over Rs 40,000 crore, and four applicants had initially bid with resolution plans. However, the committee of creditors rejected all four plans for lower bid values and a challenge mechanism was initiated in which IIHL and Torrent Investments participated.
Source: PTI
Read More On:
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Srestha Finvest
- 0.83 (+ 2.47)
- 32854884
- Vodafone Idea L
- 9.26 (+ 1.54)
- 25467695
- Filatex Fashions
- 1.01 (+ 4.12)
- 22940609
- Rajnish Wellness
- 3.31 (+ 9.97)
- 22912705
- Spicejet Ltd.
- 64.95 ( -2.29)
- 11026249
MORE NEWS
South Indian Bank Q2 Profit Up 18% to Rs 325 Cr...
South Indian Bank reported an 18% increase in Q2 profit to Rs 325 crore, driven by...
Akums Drugs Inks Licensing Pact with Canadian...
Akums Drugs and Pharmaceuticals has signed a licensing agreement with Triple Hair Inc....
Wockhardt Seeks Approval for Diabetes Drug...
Wockhardt has filed for marketing approval of its fast-acting insulin analog, Aspart...